$11.71
0.93% yesterday
Nasdaq, Oct 17, 10:00 pm CET
ISIN
US92556V1061
Symbol
VTRS

Viatris Stock price

$11.71
-0.11 0.93% 1M
+0.61 5.50% 6M
+0.88 8.13% YTD
+2.28 24.18% 1Y
-1.78 13.20% 3Y
-7.17 37.98% 5Y
-46.18 79.77% 10Y
Nasdaq, Closing price Thu, Oct 17 2024
-0.11 0.93%
ISIN
US92556V1061
Symbol
VTRS
Sector
Industry

Key metrics

Market capitalization $13.98b
Enterprise Value $30.35b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 15.66
EV/Sales (TTM) EV/Sales 2.00
P/S ratio (TTM) P/S ratio 0.92
P/B ratio (TTM) P/B ratio 0.73
Dividend yield 4.10%
Last dividend (FY23) $0.48
Revenue growth (TTM) Revenue growth -2.22%
Revenue (TTM) Revenue $15.19b
EBIT (operating result TTM) EBIT $1.48b
Free Cash Flow (TTM) Free Cash Flow $1.94b
Cash position $1.01b
EPS (TTM) EPS $-0.54
P/E forward 24.12
P/S forward 0.94
EV/Sales forward 2.05
Short interest 2.51%
Show more

Is Viatris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,907 stocks worldwide.

Viatris Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Viatris forecast:

2x Buy
18%
7x Hold
64%
2x Sell
18%

Analyst Opinions

11 Analysts have issued a Viatris forecast:

Buy
18%
Hold
64%
Sell
18%

Financial data from Viatris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
15,194 15,194
2% 2%
100%
- Direct Costs 8,931 8,931
2% 2%
59%
6,264 6,264
3% 3%
41%
- Selling and Administrative Expenses 1,170 1,170
90% 90%
8%
- Research and Development Expense 815 815
9% 9%
5%
4,279 4,279
16% 16%
28%
- Depreciation and Amortization 2,801 2,801
6% 6%
18%
EBIT (Operating Income) EBIT 1,478 1,478
30% 30%
10%
Net Profit -647 -647
135% 135%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Viatris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viatris Stock News

Neutral
PRNewsWire
one day ago
Continues to Expand Viatris' Innovative Portfolio in Cardiovascular Diseases Leverages Viatris' Unique Global Infrastructure and Expertise Includes Opportunities to Leverage the Potential of Sotagliflozin to Additional Indications PITTSBURGH , Oct. 16, 2024 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has entered into an exclusive licensing agreem...
Neutral
PRNewsWire
9 days ago
Treatment with once-daily EFFEXOR® met primary and all secondary efficacy endpoints in outpatient adults with GAD EFFEXOR® was generally well tolerated, consistent with its known safety profile Pharmaceuticals and Medical Devices Agency (PMDA) submission targeted for 2025 PITTSBURGH and TOKYO , Oct. 9, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announce...
Neutral
PRNewsWire
10 days ago
PITTSBURGH , Oct. 8, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024. This is the fourth year in a row that Viatris has received this recognition, which is presented by Forbes and Statista, the world-leading statistics portal and industry ranking provider.
More Viatris News

Company Profile

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Head office United States
CEO Scott Smith
Employees 38,000
Founded 2019
Website www.viatris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today